We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 5.625 | 5.50 | 5.75 | 5.625 | 5.375 | 5.625 | 804,647 | 12:30:03 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -1.26 | 6.47M |
From Apr 2019 to Apr 2024
TIDMGDR
RNS Number : 2372T
Genedrive PLC
11 October 2017
RNS
For release: 11 October 2017
genedrive plc ("genedrive" or the "Company")
Notice of Preliminary Results
genedrive plc (LSE: GDR), the molecular diagnostics company, will be announcing its preliminary results for the twelve months ending 30 June 2017 on Tuesday 17 October, 2017.
David Budd, Chief Executive Officer, and Matthew Fowler, Chief Financial Officer, will host a presentation and simultaneous live conference call for analysts, followed by a Q&A session, at 11:00am on the day of the results. The presentation will be held at 85 Gresham Street, London, EC2R 7HE.
- Ends -
For further details please contact:
genedrive plc
David Budd: CEO +44 (0)161 989 0245
Matthew Fowler: Finance Director
Peel Hunt LLP
James Steel
+44 (0)207 418 8900
Oliver Jackson
Consilium Strategic Communications
Chris Gardner +44 (0)203 709 5700
Matthew Neal
Laura Thornton
genedrive@consilium-comms.com
Notes to Editors
genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. Further details can be found at: www.genedriveplc.com and www.genedrive.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOROKKDNPBDDFKD
(END) Dow Jones Newswires
October 11, 2017 02:00 ET (06:00 GMT)
1 Year Genedrive Chart |
1 Month Genedrive Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
